Reirradiation With Concomitant Chemotherapy After Salvage Surgery for Recurrence of Head and Neck Cancer in Irradiated Area

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005 by Gustave Roussy, Cancer Campus, Grand Paris.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Gustave Roussy, Cancer Campus, Grand Paris
ClinicalTrials.gov Identifier:
NCT00180934
First received: September 13, 2005
Last updated: December 22, 2005
Last verified: September 2005
  Purpose

Interest of a reirradiation with concomitant chemotherapy after salvage surgery for recurrence of head and cancer in irradiated area : a multicentric Phase III randomized trial


Condition Intervention Phase
Recurrence of Head and Cancer in Irraiated Area
Procedure: Reirradiation with concomitant chemotherapy
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: Interest of a Reirradiation With Concomitant Chemotherapy After Salvage Surgery for Recurrence of Head and Neck Cancer in Irradiated Area: a Multicentric Phase III Randomized Trial

Resource links provided by NLM:


Further study details as provided by Gustave Roussy, Cancer Campus, Grand Paris:

Primary Outcome Measures:
  • Overall survival at 3 years

Secondary Outcome Measures:
  • Local event-free survival
  • Toxicity

Estimated Enrollment: 280
Study Start Date: July 1999
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • head and neck squamous cancer
  • both sexes
  • >=18 years
  • recurrence treated by surgery and initially treated by radiotherapy
  • with written informed consent at entry time

Exclusion Criteria:

-

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00180934

Locations
France
Institut Gustave Roussy
Villejuif, France, 94800
Sponsors and Collaborators
Gustave Roussy, Cancer Campus, Grand Paris
Investigators
Principal Investigator: François JANOT, MD Gustave Roussy, Cancer Campus, Grand Paris
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00180934     History of Changes
Other Study ID Numbers: JANORL, CSET 98/656
Study First Received: September 13, 2005
Last Updated: December 22, 2005
Health Authority: France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)

Additional relevant MeSH terms:
Recurrence
Head and Neck Neoplasms
Disease Attributes
Pathologic Processes
Neoplasms by Site
Neoplasms

ClinicalTrials.gov processed this record on September 18, 2014